Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

NCT: NCT05337826 · ACTIVE_NOT_RECRUITING

NCT IDNCT05337826
StatusACTIVE_NOT_RECRUITING
Start Date2022-04-20
Completion2026-05

Brief Summary

To assess the efficacy of the REST model in facilitating adoption and sustained use of CGM, in older adults with Type 1 diabetes (T1D) or Type 2 Diabetes (T2D) on complex insulin regimens. To examine barriers and enablers for the implementation feasibility of the REST intervention model using a mixed-methods approach. To assess the impact of REST model on economic factors and quality of life measures. The goal of this study is to facilitate the adoption of continuous glucose monitoring (CGM) in older adults (≥65 years) with diabetes mellitus (DM) on complex insulin regimens, and additionally, to build a framework for sustained CGM use over time using a novel patient-centered model - the REST model.

Frequently Asked Questions

What is The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes?

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes is a clinical trial registered under NCT05337826. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05337826?

The current status of NCT05337826 (The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes) is: ACTIVE_NOT_RECRUITING.

When did The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes start?

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes started on 2022-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.